Mazdutide after sleeve gastrectomy for severe obesity
Part of Hormones & metabolism clinical trials.
This study tests if adding a medicine called Mazdutide after weight-loss surgery helps people with severe obesity achieve better results. It may be an option for those who qualify and are already planning to have sleeve gastrectomy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- Your body mass index (BMI) is 37.5 or higher, with or without related health problems.
- You are scheduled to have sleeve gastrectomy surgery.
- You do not have a history of stomach or weight-loss surgery.
- You have not taken certain diabetes or weight-loss medicines like GLP-1 agonists in the last 3 months.
- You are not pregnant or breastfeeding, and if you could become pregnant, you agree to use birth control during the study and for 8 weeks after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medication called mazdutide to see if it can reduce plaque buildup in the heart arteries of people who are overweight and have a moderate narrowing. If you qualify, you may receive the drug or a placebo and will be monitored over time.
This trial tests whether adding a GLP-1 medication (a type of diabetes and weight-loss drug) after weight-loss surgery helps patients with obesity and related health conditions like diabetes. Researchers want to see if combining surgery with this medicine works better than surgery alone.
This trial tests whether combining lifestyle changes (diet and exercise) with a medication called mazdutide can help adults with obesity lose weight and keep it off. Mazdutide is an injectable medication that may help reduce appetite and support weight management over 2 years.
This trial compares getting a sleeve gastrectomy alone versus getting it along with tirzepatide (a medicine that helps with weight loss and diabetes) to see if combining them leads to more weight loss. It may help people who are having their first sleeve gastrectomy.
This study tests a once-weekly injection called mazdutide to help adults with prediabetes and higher weight lower their blood sugar and potentially lose weight. It is a double-blind, placebo-controlled trial, meaning some people get the real drug and some get a placebo (no active drug).
This trial tests if a medicine called Mazdutide can help overweight living liver donors who have a fatty liver condition (MASLD) lose weight and improve their liver health before donating part of their liver. It aims to make the donation safer and more successful.
Hear when a new Severe Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.